Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
412 Leser
Artikel bewerten:
(2)

Transparency Market Research: Generic Injectables Market to Expand at a CAGR of 5% during Forecast Period, notes TMR Study

  • In order to diversify their revenue streams, market players are expanding their R&D activities to come up with treatments for cardiological illnesses and cancer
  • Based on product type, in 2020, the category of large molecule injectables represented a significant part of the global generic injectables market.

WILMINGTON, Del., Oct. 4, 2022 /PRNewswire/ -- By 2031, the value of global generic injectables market is estimated to surpass valuation of US$ 307.7 Bn. The demand analysis of generic injectables market anticipate the market to register growth at 12.3% CAGR during the forecast period, from 2021 to 2031. By keeping robust supply chains to guard against vulnerabilities brought on by future COVID-19-like circumstances, companies in the generic injectables market are preparing for the future. Drug companies, including Zydus Cadila, have been noted to dramatically lower the cost of Remdac, their Remdesivir generic. Companies are utilizing government initiatives and financial incentives provided by the BFSI industry to simplify their operations in response to the unstable market conditions.

TMR Logo

Specialty generic injectables that come in glass vial packaging are becoming more and more popular, thereby driving sales of generic injectables market. Express Pharma, working in collaboration with West Pharma, held a webinar to help participants better understand the reasons why young generic injectable producers require flexibility and ease of use when it comes to drug delivery as well as containment.

Get Exclusive PDF Sample Copy of Generic Injectables Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42698

For the management of severe hypoglycemia that is expected to develop in people who have diabetes mellitus, the U.S. FDA has authorized the first generic version of glucagon for injection USP. The medication can be used as a diagnostic tool during radiologic examinations of colon, small bowel, stomach, duodenum, in situations where slowed intestinal motility will be helpful. Such innovations are expected to drive favorable generic injectables market outlook.

Key Findings of Market Report

Compared to other main package types, syringes are amongst the trickiest items to examine and need special handling procedures. In order to handle syringes gently and prevent glass-to-glass contact, participants in the generic injectables market are expected to use advanced inspection systems, which are emerging trends of generic injectables market. This will reduce the risk of fractures or breakage. These developments are likely to trigger expansion of the global generic injectables market

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=42698

Global Generic Injectables Market: Key Players

Some of the key market players are

  • Johnson & Johnson Services, Inc.
  • Fresenius SE & Co. KGaA
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=42698

Global Generic Injectables Market: Segmentation

Product Type

  • Large Molecule Injectables
  • Small Molecule Injectables

Application

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Diabetes
  • Immunology
  • Others

Container Type

  • Vials
  • Premix
  • Prefilled Syringes
  • Ampoules
  • Others

Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031.

Subcutaneous Immunoglobulin Market: The global subcutaneous immunoglobulin market was valued at US$ 4.0 Bn in 2018 and is anticipated to expand at a CAGR of 13.1% from 2019 to 2027.

Diabetes Devices Market: The global diabetes devices market was valued at US$ 41.8 Bn in 2018 and is anticipated to expand at a CAGR of 6.4% from 2019 to 2027.

Prefilled Syringes Market: The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031.

Disposable Syringes Market: The disposable syringes market is expected to progress at a robust CAGR of ~7% during the forecast period.

Collagen Peptide & Gelatin Market: The global collagen peptide and gelatin market is anticipated to reach more than US$ 7.8 Bn by the end of 2031.

Nanoparticle Contract Manufacturing Market: The global nanoparticle contract manufacturing market is anticipated to reach more than US$ 176.5 Bn by the end of 2031.

Catheter Stabilization Devices Market: The global catheter stabilization devices market is anticipated to reach US$ 2.6 Bn by the end of 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo - https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/generic-injectables-market-to-expand-at-a-cagr-of-5-during-forecast-period-notes-tmr-study-301639923.html

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.